NCT03947632

Brief Summary

The aim of this study was to determine the anthropometric measurements in transfusion-dependent β-thalassemia children in Pakistan. The secondary aim was to correlate serum ferritin with the physical growth

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
367

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2014

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

May 7, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 13, 2019

Completed
Last Updated

May 13, 2019

Status Verified

May 1, 2019

Enrollment Period

2 years

First QC Date

May 7, 2019

Last Update Submit

May 9, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • Height in transfusion-dependent β-thalassemia pediatric patients in Pakistan were recorded to assess growth rate

    Height in meters will be recorded from medical records of the patients

    Jan 2013 to Dec 2014

  • Weight in transfusion-dependent β-thalassemia pediatric patients in Pakistan were recorded to assess growth rate

    Wight in kilograms will be recorded from medical records of the patients

    Jan 2013 to Dec 2014

  • Assessment of physical growth in transfusion-dependent β-thalassemia pediatric patients in Pakistan were recorded to assess growth rate

    World health organization (WHO) 2007 growth charts were used for boys and girls to assess their physical growth. Body mass index (BMI) was computed as weight in kg/height in square meters (kg/m\^2). z-Score of height (h-SDS), weight (w-SDS), and BMI (BMI-SDS) were also calculated.

    Jan 2013 to Dec 2014

  • Serum ferritin levels and their association with z-Score of height

    Correlation was assessed between height for age z-score and serum ferritin levels. Serum ferritin was measured by chemi-luminescent micro-particle immunoassay on Cobos® E-601. The association of z-Score of height with median serum ferritin levels was further confirmed by comparing these laboratory parameters in children with height z-scores \<2 with those with the z-score ≥2 using the Mann-Whitney test.

    Jan 2013 to Dec 2014

Interventions

Five milliliter of blood samples were collected in two tubes (ethylenediaminetetraacetic acid and gel) at Fatimid foundation by a trained phlebotomist prior to blood transfusion to determine hemoglobin and serum ferritin.

Eligibility Criteria

Age5 Years - 17 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

367 pediatric patients (age 5-17 year) with transfusion dependent β-thalassemia were recruited. All patients were diagnosed based on hemoglobin electrophoresis or high-performance liquid chromatography. Patient recruitment was conducted at a non- profit organization named Fatimid Foundation Karachi (FFK), which provides free of cost blood components to the patients with various blood disorders.

You may qualify if:

  • Children with transfusion dependent beta thalassemia major
  • Age 5 to 17 years
  • Subjects with informed consent

You may not qualify if:

  • Age more than 17 years
  • Subjects who refused informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Five milliliter of blood samples were collected in two tubes (ethylenediaminetetraacetic acid and gel)

MeSH Terms

Conditions

beta-Thalassemia

Condition Hierarchy (Ancestors)

ThalassemiaAnemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 7, 2019

First Posted

May 13, 2019

Study Start

January 1, 2013

Primary Completion

December 31, 2014

Study Completion

December 31, 2014

Last Updated

May 13, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share